NeOnc Provides Business Update and Reports Q1 2026 Financial Results
On May 18, 2026, NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) disclosed its financial performance for the first quarter ending March 31, 2026. The clinical-stage biopharmaceutical company, focusing on advancing two Phase 2 initiatives in central nervous system (CNS) cancers, also highlighted recent operational successes and upcoming milestones.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments